MedTrace Logo

Lactate Imaging as a Tumour Biomarker

NCT01881386 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2020-01-28

No results posted yet for this study

Summary

This project is designed to investigate whether measurements of lactate in tumours, made using a magnetic resonance technique similar to MRI, is an effective non-invasive method to detect whether some new targeted drugs are having their desired effect.

The study hypothesis is that by using magnetic resonance spectroscopy techniques, we will be able to observe changes in tumour lactate levels in vivo, in response to treatment.

Conditions

Interventions

DEVICE

Magnetic Resonance Imaging (MRI)

Magnetic Resonance Spectroscopy

Sponsors & Collaborators

  • Cancer Research UK

    collaborator OTHER

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Principal Investigators

  • Nandita deSouza, Professor · ICR

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-09-01
Primary Completion
2017-09-01
Completion
2017-09-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01881386 on ClinicalTrials.gov